<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04107246</url>
  </required_header>
  <id_info>
    <org_study_id>19CH145</org_study_id>
    <secondary_id>2019-A02280-57</secondary_id>
    <nct_id>NCT04107246</nct_id>
  </id_info>
  <brief_title>Data Collection of Therapeutic Compliance in Patients Receiving Corneal Graft Using a Collection Box for Corticosteroid Eye Drops</brief_title>
  <acronym>KALICORT</acronym>
  <official_title>Data Collection of Therapeutic Compliance in Patients Receiving Corneal Graft Using a Collection Box for Corticosteroid Eye Drops</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Kali Care</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Saint Etienne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Following corneal graft, local steroids with a gradually decreasing dose for 12 months are
      prescribed to reduce the graft rejection risk (maximum incidence of 20% for the first 12
      months). The validated KaliJAR® device is a box for single-dose eye drops collection. This
      innovative tool will make it possible to objectify the compliance of patients with a corneal
      graft.

      Unlike the field of glaucoma, no specific compliance data are available for corneal grafts,
      although it is important because graft rejection is the most important cause of corneal graft
      failure.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 20, 2019</start_date>
  <completion_date type="Anticipated">September 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Ratio between the number of instilled drops / number of prescribed drops</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>patient behaviour towards corticosteroid treatment</measure>
    <time_frame>12 months</time_frame>
    <description>Compliance curve for each patient (pattern / compliance pattern). Compliance profiles versus prescribed treatment at fixed interval time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire on therapeutic compliance</measure>
    <time_frame>month 1, month 6 and month 12</time_frame>
    <description>Morisky questionnaire :
Adherence to treatment is good if the score is greater than or equal to 8. Adherence to treatment is average if the score is 6 or 7. Adherence to treatment is low if the score is less than 6.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Corneal Graft Disorder (Disorder)</condition>
  <condition>Corticosteroid</condition>
  <arm_group>
    <arm_group_label>Newly transplanted corneal patients</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>use of the KaliJAR box</intervention_name>
    <description>KaliJAR® : validated device for single-dose eye drops collection. the patient will be asked to discard each single dose of eye drops in the KaliJAR box. The patient returns with the KaliJAR box at each consultation as part of normal practice. The KaliJAR box will be emptied at each consultation by the doctor and then returned to the patient.
No further examination or visit.</description>
    <arm_group_label>Newly transplanted corneal patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Newly transplanted corneal patients and adult
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Newly transplanted corneal patients

          -  Patients able to instill correctly topical corticosteroid treatment

          -  Patients able to come to control visits

          -  Patient affiliated or entitled to a social security system

          -  Patient informed about the study and having signed a consent

        Exclusion Criteria:

          -  Patients under guardianship

          -  Patients unable to give their consent or to correctly use the collection box
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippe GAIN, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Saint Etienne</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Philippe GAIN, MD PhD</last_name>
    <phone>04 77 12 77 93</phone>
    <phone_ext>+33</phone_ext>
    <email>philippe.gain@chu-st-etienne.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marie Caroline TRONE, MD</last_name>
    <phone>04 77 12 77 93</phone>
    <phone_ext>+33</phone_ext>
    <email>marie-caroline.trone@chu-st-etienne.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU de Saint Etienne</name>
      <address>
        <city>Saint Etienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie Caroline TRONE, MD</last_name>
      <phone>(0)4 77 12 70 12</phone>
      <phone_ext>+33</phone_ext>
      <email>m.caroline.trone@chu-st-etienne.fr</email>
    </contact>
    <investigator>
      <last_name>Marie Caroline TRONE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philippe GAIN, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gilles THURET, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Caroline RONIN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nicolas PERRILAT COLLOMB, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thibaud GARCIN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>September 25, 2019</study_first_submitted>
  <study_first_submitted_qc>September 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 27, 2019</study_first_posted>
  <last_update_submitted>July 21, 2020</last_update_submitted>
  <last_update_submitted_qc>July 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

